Hypoactive sexual desire disorder (HSDD) refers to a woman’s chronic or ongoing lack of interest in sex, to the point that it causes her personal distress or problems in her relationships. To evaluate the efficacy and safety of subcutaneously administered Bremelanotide (BMT) in pre-menopausal Women with Hypoactive Sexual Desire Disorder (HSDD). Register Today!
Diabetes is treatable, but even when glucose levels are under control it greatly increases the risk of heart disease and stroke. That’s because people with diabetes, particularly type 2 diabetes, often have the following conditions that contribute to their risk for developing cardiovascular disease. High blood pressure (hypertension) Abnormal cholesterol and high triglycerides Obesity Lack…
Crohn’s disease is an inflammatory bowel disease (IBD). It causes inflammation of the lining of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people. The inflammation caused by Crohn’s disease often spreads…
A Phase IIIb open-label, randomised, multi-centre primary immunization study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine when administered intramuscularly according to alternative 2-dose schedules in 9 – 14 year old healthy females compared to the standard 3-dose schedule for GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in 15…
A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes. Register Today!
A Phase 3, Randomized, Active-Controlled, Observer-Blinded Trial To Assess The Lot Consistency, Safety, Tolerability, And Immunogenicity Of A Meningococcal Serogroup B Bivalent Rlp2086 Vaccine In Healthy Subjects Aged 10 To <19 Years. Register Today!
A phase II observer-blind, randomized, controlled, multi-center trial to evaluate the safety and immunogenicity of different formulations of monovalent Influenza A/mallard/Netherlands/12/2000 NIBRG-63 (H7N1) vaccine manufactured in Quebec, Canada with AS03 adjuvant, given as a two-dose series to adults 65 years of age and older. Register Today!
A phase I/II single-blind, randomized, controlled, multi-center trial to evaluate the safety and immunogenicity of different formulations of monovalent Influenza A/mallard/Netherlands/12/2000 NIBRG-63 (H7N1) vaccine manufactured in Quebec, Canada with and without AS03 adjuvant, given as a two-dose series to adults 21 to 64 years of age. Register Today!
Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-Term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD. Register Today!
A Phase III, Stratified, Randomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to < 72 Months of Age. Register Today!
